Press Releases
Clinical Trials
Greenphire Enhances Its Participant Payment and Reimbursement Solution to Further Support Remote Clinical Trials
As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid or remote clinical trial designs. The alternative would be to suspend the trial and...
Press Releases
Thermo Fisher Scientific to Double its Capacity of Viral Vector Manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, announced it is expanding capacity for viral vector development and manufacturing services with construction of a new commercial manufacturing site in Plainville, Mass. The $180 million project will more...
Drug Research
Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine through the sharing of...
Press Releases
Sterling Pharma Solutions commence the production of potential COVID-19 treatment
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
Sterling will be manufacturing the active pharmaceutical ingredient (API) with the finished product being manufactured and supplied...
Press Releases
Abbott Earns Emergency Use Authorization for Another COVID-19 Antibody Test
Abbott Laboratories has won Emergency Use Authorization for another COVID-19-related diagnostics test for antibodies. This morning, the company said the U.S. Food and Drug Administration approved its SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system.
With the...
Press Releases
Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse Inhaled Nitric Oxide Therapy to Treat COVID-19
Bellerophon Therapeutics, Inc., a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious lung diseases, announced that the U.S. FDA accepted its Investigational New Drug (IND) application, allowing the Company to initiate a Phase 3 study of...
Drug Research
Pfizer Outsources Branded Drug Production to Focus on Experimental Coronavirus Vaccine
Pfizer is taking on significant risk in a race to provide the world with a coronavirus vaccine. Pfizer is outsourcing the production of its own branded medicines to contract manufacturers such as Catalent to make room for the production...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















